Skip to main content
Equibles

PRUDENTIAL FINANCIAL INC

Position in MYGN — Myriad Genetics Inc

CIK 1137774 NEWARK, NJ
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$3,523,429
+$1,808,376 QoQ
Shares Held
617,063
+61.9% QoQ
Ownership
0.645%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 196 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

PRUDENTIAL FINANCIAL INC holds $508,830,839 across 26 Diagnostics & Research names. MYGN ranks #16 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DHR
Danaher Corp /De/
 1,121,640 $213,649,986
2 TMO
Thermo Fisher Scientific Inc.
 250,169 $125,424,729
3 A
Agilent Technologies, Inc.
 155,854 $20,702,086
4 IDXX
Idexx Laboratories Inc /De
 37,173 $19,569,353
5 WAT
Waters Corp /De/
 46,340 $17,379,353
6 IQV
Iqvia Holdings Inc.
 86,421 $16,698,264
7 MTD
Mettler Toledo International Inc/
 10,100 $12,902,850
8 VCYT
Veracyte, Inc.
 219,590 $12,896,520

All Filings in MYGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,523,429 617,063
2026-03-31 $1,715,053 381,123
2025-12-31 $646,961 105,197
2025-09-30 $784,339 108,484
2025-06-30 $1,819,652 342,684
2025-03-31 $1,558,113 175,661
2024-12-31 $2,867,186 209,131
2024-09-30 $9,194,302 335,681
2024-06-30 $2,864,803 117,122
2024-03-31 $2,493,096 116,937
2023-12-31 $1,935,666 101,132
2023-09-30 $1,534,434 95,663
2023-06-30 $2,757,562 118,963
2023-03-31 $2,338,331 100,660
2022-12-31 $1,509,358 104,022
2022-09-30 $2,100,611 110,095
2022-06-30 $2,201,203 121,145
2022-03-31 $2,842,256 112,788
2021-12-31 $6,220,432 225,378
2021-09-30 $11,405,828 353,231
2021-06-30 $10,510,742 343,713
2021-03-31 $13,170,142 432,517
2020-12-31 $6,038,092 305,417
2020-09-30 $2,855 219
2020-06-30 $2,120 187
2020-03-31 $2,947 206